This is not the most recent version of the article. View current version (29 JUL 2014)

Intervention Protocol

Hepatitis B immune globulin for prevention of posttransplantation hepatitis B

  1. Zhiyong Hong1,*,
  2. Ru Nie Gao2,
  3. Shimian Zou3

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 18 OCT 2004

DOI: 10.1002/14651858.CD004995


How to Cite

Hong Z, Gao RN, Zou S. Hepatitis B immune globulin for prevention of posttransplantation hepatitis B (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004995. DOI: 10.1002/14651858.CD004995.

Author Information

  1. 1

    Blood-Borne Pathogens Division Bureau of Infectuous Diseases, Health Canada, Ottawa Ontario, Ontario, Canada

  2. 2

    Health Canada, Cancer Control Assessment Surveillance Section Cancer Division CCDPC PPHB, Ottawa Ontario, Canada

  3. 3

    Health Canada, Health Care Acquired Infection Division, Ottawa Ontario, Canada

*Zhiyong Hong, Health Canada, Blood-Borne Pathogens Division Bureau of Infectuous Diseases, Health Canada Bldg No.6 AL 0601E2 Tunney`s Pasture, Tunney's Pasture, Ottawa Ontario, Ontario, K1A 0L2, Canada. Zhiyong_Hong@hc-sc.gc.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2004

SEARCH

This is not the most recent version of the article. View current version (29 JUL 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects and optimum schedule and duration of HBIG for prevention of post transplantation hepatitis B infection.